LATITUDE Study HIV: UAB NEJM Breakthrough | AcademicJobs
NEJM publishes UAB-led LATITUDE study showing monthly cabotegravir-rilpivirine injections superior for HIV patients with adherence challenges, slashing regimen failure by nearly half.
clinical-trialsresearch-publication-newsantiretroviral-therapy

